Home / Ingredients / Turmeric / curcumin
Promising evidence in some outcomes, including osteoarthritis, but formulations vary and authoritative reviews do not support blanket efficacy claims.
NCCIH says there is not enough evidence to definitively conclude that turmeric or curcumin is beneficial for any broad health purpose, though research in osteoarthritis and several other areas is active. Meta-analyses of osteoarthritis trials report symptom improvements in some settings.
Bioavailability varies greatly across curcumin formulations. Evidence from a standardized high-bioavailability extract should not be generalized to ordinary turmeric powder.
Conventional oral turmeric/curcumin appears generally tolerated short term, but gastrointestinal adverse effects occur. NCCIH warns that some highly bioavailable formulations have been linked to liver injury.
Multiple products list turmeric or curcumin-related ingredients, but dose and formulation details are often missing. Finished-product joint, anti-inflammatory, or metabolic claims remain unverified until those details match the studies.
The efficacy of curcumin in relieving osteoarthritis: A meta-analysis of meta-analyses (Umbrella meta-analysis of prior meta-analyses of randomized controlled trials; PMID 38576215)
Population/scope: 11 included meta-analyses of osteoarthritis trials
Evidence scope: Pain, WOMAC total, function, and stiffness outcomes in osteoarthritis
Finding: Pooled umbrella-level analyses favored curcumin for multiple osteoarthritis pain and function outcomes.
Limitations: Underlying trials and meta-analyses used varied curcumin formulations, doses, and methods; results do not establish equivalence across curcumin products or ordinary turmeric powder.
Directness: Relevant human evidence · verified 2026-10-02
Important: Ingredient-level evidence is not proof that a finished product has the same effect. Dose, form, population, duration, and formulation must match.
For informational purposes only; not individualized medical advice.